CJC-1295 No DAC 10 mg – GHRH Signalling | Short-Acting Endocrine Research | Premium Research Compound

A premium research compound supplied in a convenient 10 mg vial.

CJC-1295 No DAC is a synthetic analogue of growth hormone-releasing hormone, commonly abbreviated as GHRH. It is investigated for its interaction with GHRH receptors, pulsatile growth hormone signalling, endocrine activity, and related cellular pathways.

What’s Included

• 1x CJC-1295 No DAC 10 mg vial

• Over 99% Purity

• Premium-quality research compound

• Shipped from the Gold Coast, Queensland

• Australia Post Express Post

Why Choose CJC-1295 No DAC 10 mg?

CJC-1295 No DAC is commonly associated with Modified GRF (1-29) and is designed for shorter-duration research than the DAC-containing version.

Because it does not contain the Drug Affinity Complex, it does not have the same albumin-binding properties or extended research profile as CJC-1295 with DAC.

Researchers investigate CJC-1295 No DAC in relation to:

• GHRH receptor activity

• Pulsatile growth hormone signalling

• Pituitary communication

• IGF-1-related pathways

• Neuroendocrine activity

• Metabolic signalling

• Cellular repair processes

CJC-1295 No DAC Research

CJC-1295 No DAC is commonly investigated in laboratory and preclinical studies relating to:

• Growth hormone-releasing hormone pathways

• Short-duration GHRH receptor activity

• Pulsatile growth hormone release

• Pituitary and hypothalamic signalling

• IGF-1-associated biological processes

• Protein-synthesis pathways

• Cellular recovery and tissue remodelling

• Metabolic and body-composition mechanisms

• Sleep-associated endocrine activity

Research continues into how its shorter research profile influences natural growth hormone pulse patterns and downstream endocrine signalling.

No DAC vs With DAC

The key difference is the duration and pattern of research activity:

• CJC-1295 No DAC is investigated for shorter-duration, pulse-like GHRH signalling.

• CJC-1295 with DAC is designed to bind with albumin and produce a longer-lasting research profile.

This makes the No DAC version suitable for research focused on more time-specific GHRH receptor activity.

Premium Research Compound. One Easy Order.

OZZ Peptides CJC-1295 No DAC 10 mg provides researchers with a convenient option for investigating short-acting GHRH and growth hormone-related pathways.

Securely packed and shipped directly from the Gold Coast using Australia Post Express Post.

Product Highlights

🧬 GHRH Analogue
Studied for its interaction with growth hormone-releasing hormone receptors.

⏱️ Shorter Research Profile
Does not contain the Drug Affinity Complex found in the longer-acting DAC version.

📈 Pulsatile-Signalling Research
Investigated in relation to time-specific growth hormone release patterns.

🔬 Growth Hormone Pathway Research
Used in studies examining growth hormone and IGF-1-associated signalling.

⚡ Neuroendocrine Research
Studied in connection with pituitary, hypothalamic, metabolic, and cellular processes.

💎 Over 99% Purity
Premium-quality research compound.

📦 Fast Australian Delivery
Sent using Australia Post Express Post.

🌴 Gold Coast Based
Packed and shipped by the OZZ Peptides team in Queensland.

What You’ll Receive

• 1x CJC-1295 No DAC 10 mg vial

• Securely packed for delivery

• Australia Post Express Post

Storage

Store according to the storage information supplied with the product.

Before reconstitution, keep the vial in a cool, dry environment away from direct sunlight. After reconstitution, appropriate refrigerated storage may be required depending on the research protocol.

Important Information

Products supplied by OZZ Peptides are intended for laboratory research purposes only and are not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease.

OZZPEPTIDES.COM